Acta Ophthalmologica 2014

Further laboratory testing revealed elevated white blood cell count (21.8 9 109/l, reference interval: 3.5– 8.8 109/l), C-reactive protein (36 mg/l, reference value

Combined therapy with intravitreal bevacizumab and posterior subtenon triamcinolone acetonide injection in diabetic macular oedema.

Combined therapy with intravitreal bevacizumab and posterior subtenon triamcinolone acetonide injection in diabetic macular oedema. - PDF Download Free
272KB Sizes 0 Downloads 0 Views